Packaging method of probiotic single cells with acid resistance, oxidation resistance and strong adhesion and probiotics obtained through packaging

The metal ion/polyphenol coordination complex encapsulation of probiotics is formed to form an acid-resistant, antioxidant and strong adhesion encapsulation layer, which solves the problem of probiotics in the gastrointestinal tract and significantly improves its acid resistance and antioxidant resistance. ability to ensure the activity and function of probiotics.

CN118909779APending Publication Date: 2024-11-08FUZHOU UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410908747.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Probiotics are inactivated in the gastrointestinal tract due to the action of acidic environment and digestive enzymes, resulting in their colonization and proliferation in the gastrointestinal tract and affecting the performance of their probiotic functions.

Method used

The metal ion/polyphenol coordination complex is used to encapsulate probiotics to form an acid-resistant, oxidative and strong adhesion encapsulation layer. By exploring the mixing ratio of probiotics, metal ions and polyphenols, the metal-phenol network structure is formed to improve the Acid resistance and gastrointestinal environmental adaptability of probiotics.

Benefits of technology

It significantly improves the acid resistance and antioxidant ability of probiotics, enhances its survival and colonization ability in the gastrointestinal tract, ensures the activity and function of probiotics, and is suitable for the preparation of oral probiotic products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909779A_ABST
    Figure CN118909779A_ABST
Patent Text Reader

Abstract

The invention relates to a packaging method of probiotic single cells with acid resistance, oxidation resistance and strong adhesion and probiotics obtained through packaging, and the packaging method comprises the following steps: metal ions and polyphenol are mixed according to a certain mixing ratio, a uniform packaging layer is formed on the surfaces of the cells under the coordination action, and the packaged probiotics are obtained. The probiotic single cell packaging method is simple in process and easy to operate, and a uniform and compact functional coating can be formed on the surface of a single probiotic. The polyphenol-metal encapsulation layer provided by the invention not only endows the probiotics with excellent gastrointestinal digestion resistance, but also enhances the in-vitro oxidation resistance and adhesion ability of the probiotics, can protect cells from being damaged by the adversity environment of the gastrointestinal tract, keeps the activity of the probiotics, and improves the colonization of the probiotics in the intestinal tract.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of microorganisms, and in particular to a method for encapsulating single-cell probiotic bacteria with acid resistance, oxidation resistance and strong adhesion, and the encapsulated probiotic bacteria. Background Art

[0002] Probiotics are a type of active microorganisms that are beneficial to human health and have physiological characteristics such as regulating body metabolism and enhancing immunity. Studies have found that probiotics can regulate the functions of other organs through the microbiome-gut-brain axis, the microbiome-gut-lung axis, and the microbiome-gut-liver axis. In 2020, the Chinese Society of Food Science and Technology clarified the three core characteristics of probiotics in the article "Scientific Consensus on Probiotics (2020 Edition)" - sufficient quantity, viable bacteria, and beneficial health functions. In order to ensure that probiotics can bring about health-promoting effects, the recommended intake of probiotics is mainly 10 7 -10 11 CFU / d. On the basis of ensuring the number of probiotics, probiotics should also be able to effectively attach to the intestinal epithelium to obtain continuous intestinal colonization. In recent years, with the substantial increase in demand for probiotic products in my country, my country's probiotic industry has developed rapidly and has become one of the important engines supporting and driving the healthy transformation and upgrading of my country's food industry.

[0003] After oral administration of probiotics, the strong acidic environment (pH 1-3) in the stomach and the presence of digestive enzymes will increase the permeability of the probiotic cell wall and cell membrane, thereby increasing their sensitivity to damage, causing the integrity of the cell structure to be severely damaged in the stomach. Therefore, except for acid-resistant probiotics, most probiotics will be inactivated in the stomach, resulting in a significant decrease in their vitality. The digestive juice contained in the intestinal juice can also act on the microbial cell membrane, increase the permeability of the cell membrane, and cause the outflow of cell contents and cell death. In addition, the intestine contains a large number of microorganisms that can compete with probiotics for survival, thereby affecting the survival of probiotics. Therefore, the low pH value of the stomach, enzyme degradation, the antibacterial activity of bile salts, and competition with other bacteria will cause a large number of probiotics to die, which will limit the colonization and proliferation of probiotics in the gastrointestinal tract, and thus lead to a decrease in their probiotic function. Therefore, how to protect probiotics from surviving in a "dangerous" environment is a huge challenge facing the current probiotic industry.

[0004] Therefore, we proposed a probiotic single-cell encapsulation method to solve the above problems. Summary of the invention

[0005] The purpose of the present invention is to provide a method for encapsulating probiotic single cells and the encapsulated probiotics. The probiotics obtained by the encapsulation method have acid resistance, antioxidant and strong adhesion effects, and can effectively solve the problem of limited colonization and proliferation of probiotics in the gastrointestinal tract.

[0006] The purpose of the present invention is achieved through the following technical solutions:

[0007] A method for encapsulating probiotic single cells with acid resistance, oxidation resistance and strong adhesion comprises the following steps:

[0008] (1) resuspending the probiotics in a buffer to prepare a probiotic solution;

[0009] (2) adding a metal salt aqueous solution to the probiotic solution obtained in step (1) and vortexing;

[0010] (3) adding the polyphenol solution to the solution obtained in step (2), vortexing, and obtaining a bacterial suspension;

[0011] (4) centrifuging the bacterial suspension obtained in step (3);

[0012] (5) resuspending and centrifuging with PBS buffer to remove unbound polyphenols to obtain encapsulated probiotics, i.e., encapsulated probiotics;

[0013] Among them, in the encapsulation system formed by mixing the probiotic solution, the metal salt aqueous solution and the polyphenol solution, the concentration of the probiotic solution is: 1×10 7- 1×10 9 CFU / mL, the metal ion concentration is 0.004-1mmol / mL, the hydroxyl concentration of the polyphenol is 0.002-0.05mmol / mL, and the molar concentration of the metal ions in the whole system is not less than the molar concentration of the hydroxyl contained in the polyphenol in the polyphenol solution.

[0014] The polyphenol is dissolved in a PBS (pH 7.4) buffer solution to form a polyphenol solution. The PBS (pH 7.4) buffer solution is composed of disodium hydrogen phosphate, potassium dihydrogen phosphate, sodium chloride and potassium chloride, and has a pH of 7.4.

[0015] The operation method of step (1) is as follows:

[0016] The cultured probiotics were washed three times with PBS buffer and 1×10 7- 1×10 9 The probiotics at CFU / mL were resuspended in 450 μL PBS buffer with a pH of 7.4 and vortexed for 15 s to evenly disperse the bacteria.

[0017] The operation method of step (2) is: add 50 μL of metal salt aqueous solution to the probiotic solution obtained in step (1), and vortex rapidly for 15 seconds.

[0018] The operation method of step (3) is as follows: add 500 μL of polyphenol solution to the solution obtained in step (2), vortex for 15 seconds, and obtain a bacterial suspension.

[0019] The operation method of step (4) is:

[0020] Centrifuge the bacterial suspension obtained in step (3) at 12000 rpm / min for 5-10 min;

[0021] The operation method of step (5) is:

[0022] The product obtained in step (4) is resuspended three times with PBS buffer and centrifuged at 5000-12000 rpm / min for 5-10 minutes to remove unbound polyphenols, thereby obtaining encapsulated probiotics, i.e., encapsulated probiotics.

[0023] The polyphenol is one or a mixture of tea polyphenols, proanthocyanidins, ellagic acid or catechin compounds.

[0024] The catechin compound is one or a mixture of epigallocatechin gallate (EGCG), epicatechin gallate (ECG), epigallocatechin (EGC), and epicatechin (EC).

[0025] The metal salt aqueous solution is an aqueous solution of a transition metal salt; the transition metal salt is one or a mixture of zinc salt, iron salt and manganese salt.

[0026] The zinc salt may be zinc acetate, zinc sulfate, zinc gluconate, etc., the iron salt may be ferric sulfate, ferric chloride, ferrous sulfate, etc., and the manganese salt may be manganese chloride, manganese sulfate, etc.

[0027] The corresponding metal ions are zinc ions, iron ions and manganese ions.

[0028] The probiotics are any one of fermented mucus lactobacillus, salivary lactobacillus, bacillus licheniformis, rhamnosus lactobacillus, paracasei lactobacillus, plant lactobacillus, and thermophilic streptococcus, or a mixture of several of them.

[0029] The present invention also provides encapsulated probiotics obtained by encapsulating the method.

[0030] The encapsulated probiotics of the present invention are used in the preparation of oral probiotic products.

[0031] Polyphenols can form a supramolecular three-dimensional network structure, i.e., a metal-phenol network structure (MPN), with ions of multivalent metals (such as Fe, Ti, Mn, and Cr) through coordination bonds. Although there have been many studies on MPN, there are no reports on the simultaneous improvement of probiotic acid resistance, gastrointestinal environmental tolerance, anti-oxidation, and strong adhesion by encapsulating probiotics with a metal-phenol network structure. Studies have shown that the MPN structure composed of tannic acid will immediately disintegrate at pH 2, so the structure cannot provide sufficient protection for probiotics in gastric acid. The current solution to this problem is to use a double-layer encapsulation with a more complicated process, that is, to add another layer of material with acid resistance to the outer layer of MPN, and this method usually has the disadvantages of cumbersome process and high cost. The present invention explores the mixing ratio of probiotics, metal ions, and polyphenols, and uses metal ion / polyphenol coordination complexes to encapsulate probiotics. The encapsulation layer formed successfully gives probiotics acid resistance, anti-oxidation, and strong adhesion. The encapsulated probiotics and the encapsulation method are expected to be used in the preparation of oral probiotic products.

[0032] Compared with the prior art, the advantages of the present invention are:

[0033] The invention uses metal ion / polyphenol coordination complexes to encapsulate probiotics, and by exploring the mixing ratio of probiotics, metal ions, and polyphenols, successfully encapsulates and forms probiotics with significant acid resistance, antioxidant properties, and strong adhesion, namely, encapsulated probiotics. The encapsulation method and the encapsulated probiotics are expected to be used in the preparation of oral probiotic products.

[0034] The acid-resistant, antioxidant and strongly adherent probiotic single-cell encapsulation method of the present invention has mild preparation conditions, simple and easy process, and ensures the activity of probiotics. The polyphenols and metal salts used are cheap and easy to obtain, and the network structure formed by the coordination of metals and polyphenols can enhance the resistance of probiotics to the external environment. Transmission electron microscopy and confocal microscopy show that the coating is successful. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 These are the results of simulated gastric juice digestion after encapsulating and fermenting Lactobacillus mucilaginosus at different metal concentrations in Examples 1-5.

[0036] Figure 2 These are the digestion results of simulated gastric juice and simulated intestinal juice after encapsulating and fermenting Lactobacillus mucosa at different metal concentrations in Examples 1-5.

[0037] Figure 3 The simulated gastric digestion results after using different metal encapsulated probiotics in Examples 6-8 are shown.

[0038] Figure 4 These are the results of simulated gastric juice digestion after encapsulating and fermenting Lactobacillus mucilaginosus in Examples 9-10 using metal concentrations lower than those specified in the present invention.

[0039] Figure 5 These are the results of simulated gastric juice digestion after encapsulating different probiotics using the method specified in the present invention in Examples 11-16.

[0040] Figure 6 The results of simulated gastric digestion after using different polyphenols to encapsulate probiotics in Examples 17-22 are shown.

[0041] Figure 7 This is a graph showing the growth curve of the fermented mucus lactobacillus in Example 3 before and after digestion with simulated gastric juice and intestinal juice.

[0042] Figure 8 The particle size change curve of the fermented mucus lactobacillus before and after encapsulation in Example 3 is shown.

[0043] Fig. 9 This is a bar graph showing the change in zeta potential of the fermented mucus Lactobacillus before and after encapsulation in Example 3.

[0044] Fig.10 These are laser confocal microscopy images of the fermented mucus Lactobacillus in Example 3 before and after encapsulation.

[0045] Fig.11 Transmission electron microscope images of the fermented mucus Lactobacillus before and after encapsulation in Example 3.

[0046] Fig.12 The free radical scavenging ability of the fermented mucus Lactobacillus before and after encapsulation in Example 3 is compared.

[0047] Fig.13 This is a laser confocal microscope image of the accumulation of active oxygen in the cells of the fermented mucus Lactobacillus before and after encapsulation in Example 3.

[0048] Fig.14 The figure is a comparison of the in vitro adhesion ability of the fermented mucus Lactobacillus before and after encapsulation in Example 3. DETAILED DESCRIPTION

[0049] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0050] The probiotics used in the present invention, such as fermented Lactobacillus mucilaginosus, Lactobacillus salivarius, Bacillus licheniformis, Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus plantarum and Streptococcus thermophilus, are all existing bacteria and can be purchased from corresponding manufacturers.

[0051] The present invention utilizes an encapsulation system consisting of probiotics, a metal salt aqueous solution, and a polyphenol solution to encapsulate a variety of probiotic single cells (encapsulated probiotics) that are acid-resistant, antioxidant, and strongly adherent. The specific encapsulation method is shown in Examples 1 to 22:

[0052] Embodiment 1:

[0053] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer. 9 CFULlf was resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 16.5 mg / mL (i.e. 0.09 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds to obtain a bacterial suspension (in the encapsulation system, the concentration of the probiotic solution is: 10 9 CFU / mL, metal ion concentration was 0.0045mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min for 5min, resuspended 3 times with PBS buffer and centrifuged at 5000-12000rpm / min for 5-10min to remove unbound EGCG, thereby obtaining encapsulated probiotic CoatedLlf1.

[0054] Embodiment 2:

[0055] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 9 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 18.3 mg / mL (i.e. 0.10 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 9 CFU / mL, metal ion concentration was 0.005mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf2.

[0056] Embodiment 3:

[0057] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 9 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 9 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf3.

[0058] Embodiment 4:

[0059] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 9 The probiotics of CFU were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 29.4 mg / mL (i.e. 0.16 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 9 CFU / mL, metal ion concentration was 0.008mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf4.

[0060] Embodiment 5:

[0061] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 9CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 36.7 mg / mL (i.e. 0.20 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 9 CFU / mL, metal ion concentration was 0.01mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf5.

[0062] Embodiment 6:

[0063] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 32 mg / mL (i.e. 0.12 mmol / mL) chromium trichloride hexahydrate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf6.

[0064] Embodiment 7:

[0065] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 7 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 20.3 mg / mL (i.e. 0.12 mmol / mL) monohydrated manganese sulfate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 7CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf7.

[0066] Embodiment 8:

[0067] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL zinc ion and iron ion composite aqueous solution was added, wherein the composite aqueous solution was composed of 18.3 mg / mL (0.10 mmol / mL) zinc acetate aqueous solution and 17.6 mg / mL (0.065 mmol / mL) ferric chloride hexahydrate aqueous solution in a ratio of 7:1. Vortexed quickly for 15 seconds, then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution is: 10 8 CFU / mL, metal ion concentration was 0.0048mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf8.

[0068] Embodiment 9:

[0069] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 The probiotics of CFU were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 11 mg / mL (i.e. 0.06 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.003mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf9.

[0070] Embodiment 10:

[0071] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 The probiotics of CFU were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 5 μL 10.1 mg / mL (i.e. 0.055 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 400 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.000275mmol / mL, and hydroxyl concentration of polyphenols was 0.0035mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf10.

[0072] Embodiment 11:

[0073] The cultured Lactobacillus paracasei (Lbp) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLbp 11.

[0074] Embodiment 12:

[0075] The cultured Lactobacillus plantarum (Lpp) was washed three times with PBS (pH 7.4) buffer and 10 8CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLpp 12.

[0076] Embodiment 13:

[0077] The cultured Streptococcus thermophilus (Stt) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed 3 times with PBS to obtain encapsulated probiotics Coated Stt 13.

[0078] Embodiment 14:

[0079] The cultured Lactobacillus salivarius (Lls) was washed three times with PBS (pH 7.4) buffer, and 10 8 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed 3 times with PBS to obtain encapsulated probiotics CoatedLls 14.

[0080] Embodiment 15:

[0081] The cultured Bacillus licheniformis (Bl) was washed three times with PBS (pH 7.4) buffer, and 10 8 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed 3 times with PBS to obtain encapsulated probiotics CoatedBl 15.

[0082] Embodiment 16:

[0083] The cultured Lactobacillus rhamnosus (Lbr) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 22 mg / mL (i.e. 0.12 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGCG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8 CFU / mL, metal ion concentration was 0.006mmol / mL, and hydroxyl concentration of polyphenols was 0.0044mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLbr 16.

[0084] Embodiment 17:

[0085] The cultured Lactobacillus paracasei (Lbp) was washed three times with PBS (pH 7.4) buffer and 10 8 The probiotics of CFU were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 28.8 mg / mL (i.e. 0.1 mmol / mL) zinc sulfate heptahydrate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EGC solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution is: 10 8 CFU / mL, metal ion concentration was 0.005mmol / mL, and hydroxyl concentration of polyphenols was 0.0049mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLbp 17.

[0086] Embodiment 18:

[0087] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 7 The probiotics of CFU were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 14.7 mg / mL (i.e. 0.08 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL ECG solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution is: 10 7 CFU / mL, metal ion concentration was 0.004mmol / mL, and hydroxyl concentration of polyphenols was 0.004mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf18.

[0088] Embodiment 19:

[0089] The cultured Lactobacillus salivarius (Lls) was washed three times with PBS (pH 7.4) buffer, and 10 8CFU of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 29.4 mg / mL (i.e. 0.16 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.5 mg / mL EC solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution is: 10 8 CFU / mL, metal ion concentration was 0.008mmol / mL, and hydroxyl concentration of polyphenols was 0.0043mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLls 19.

[0090] Embodiment 20:

[0091] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU / mL of probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 44 mg / mL (i.e. 0.24 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.8 mg / mL gallic acid solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution is: 10 8 CFU / mL, metal ion concentration was 0.012mmol / mL, and hydroxyl concentration of polyphenols was 0.009mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf20.

[0092] Embodiment 21:

[0093] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 The probiotics of CFU were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 33 mg / mL (i.e. 0.18 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.8 mg / mL proanthocyanidin solution was added and vortexed for 15 seconds (in the encapsulation system, the concentration of the probiotic solution was: 10 8CFU / mL, metal ion concentration was 0.009mmol / mL, and hydroxyl concentration of polyphenols was 0.0067mmol / mL). The obtained bacterial suspension was centrifuged at 12000rpm / min and washed with PBS for 3 times to obtain encapsulated probiotics CoatedLlf21.

[0094] Embodiment 22:

[0095] The cultured Lactobacillus fermentum (Llf) was washed three times with PBS (pH 7.4) buffer and 10 8 CFU probiotics were resuspended in 450 μL PBS (pH 7.4) buffer and vortexed for 15 seconds to disperse the bacteria evenly; then 50 μL 29.4 mg / mL (0.16 mmol / mL) zinc acetate aqueous solution was added and vortexed for 15 seconds; then 500 μL 0.6 mg / mL ellagic acid solution was added and vortexed for 15 seconds. (In the encapsulation system, the concentration of the probiotic solution is: 1×10 8 CFU / mL, metal ion concentration was 0.008 mmol / mL, and hydroxyl concentration of polyphenols was 0.004 mmol / mL) The obtained bacterial suspension was centrifuged at 12000 rpm / min and washed three times with PBS to obtain encapsulated probiotics CoatedLlf22.

[0096] In Examples 1-22, the polyphenols are dissolved in PBS (pH 7.4) buffer to form polyphenol solutions such as EGCG solutions, ECG solutions, etc.; the encapsulation methods of Examples 1-22 are similar, and the probiotics, metal salts, polyphenols, metal ion concentrations of metal salts, and hydroxyl concentrations contained in polyphenols used in each example are shown in Table 1:

[0097] Table 1

[0098]

[0099] The inventors of the present invention also conducted digestive tract tolerance tests, characterization of encapsulated probiotics, in vitro efficacy evaluation of encapsulated probiotics, etc. on each encapsulated probiotic obtained in Examples 1-22, as follows:

[0100] 1. Gastrointestinal tolerance test of encapsulated probiotics:

[0101] Unencapsulated fermented Lactobacillus mucilaginosus (Llf) and encapsulated Llf cells prepared in Examples 1-5 were placed in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) containing pepsin for a period of time to evaluate the in vitro tolerance of probiotic cells, and the number of surviving cells was detected by plate counting method ( Figure 1 and Figure 2 ).

[0102] Before SGF treatment, the viable count of Example 1-5 was 9.19 Log 10 CFUs, while after 1 hour of SGF solution treatment, the Llf group had only 3.28Log 10 CFUs survived, while CoatedLlf1, CoatedLlf2, Coated Llf3, CoatedLlf4 and CoatedLlf5 had 8.59Log 10 CFUs, 8.79Log 10 CFUs, 9.07Log 10 CFUs, 9.09Log 10 CFUs and 9.19Log 10 CFUs are viable cells.

[0103] This indicates that, in the encapsulation system (composed of probiotics, metals and polyphenols), when the molar concentration of metal ions is not less than the molar number of hydroxyl groups contained in catechins, the encapsulation layer formed has obvious acid resistance.

[0104] At the same time, Llf and CoatedLlf prepared in Examples 1-5 were treated with SGF solution for 1 hour and then immediately treated with SIF solution for 3 hours, and then coated and counted for viable bacteria. Figure 2 It can be found that no bacteria survived in the Llf group, while CoatedLlf1, CoatedLlf2, CoatedLlf3, CoatedLlf4 and CoatedLlf5 had 8.41Log 10 CFUs, 8.58Log 10 CFUs, 8.86Log 10 CFUs, 8.86Log 10 CFUs and 8.88Log 10 CFUs are viable cells.

[0105] This indicates that the protective layer formed by catechin-metal can not only protect against H + It enters the "armor" of the cell membrane and also has a certain intestinal fluid protection effect, thereby improving the gastrointestinal digestion tolerance of probiotics.

[0106] In addition, Examples 6-8 used different types of metal ions to encapsulate probiotics and explored their acid resistance. The results showed that the acid resistance of probiotics can be significantly improved after encapsulating probiotics using the encapsulation method proposed in the present invention ( Figure 3 ), among which CoatedLlf6, CoatedLlf7 and CoatedLlf8 have 7.65Log 10CFUs, 7.68Log 10 CFUs and 8.63Log 10 However, when the concentration of metal ions decreases (Examples 9 and 10, Figure 4 ), CoatedLlf9 and CoatedLlf10 are only 5.10Log 10 CFUs and 3.94Log 10 The viable cell survival of CFUs indicates that when the polyphenol concentration remains unchanged and the metal ion concentration is lower than the concentration specified in the present invention, the acid protection effect of the formed encapsulation layer on the probiotics is greatly reduced.

[0107] In addition, according to the acid resistance results of the probiotics obtained in Examples 3, 6, 7, and 8, it can be seen that the probiotics obtained by encapsulating the probiotics (fermented mucus Lactobacillus) with zinc ions and EGCG have stronger acid resistance than the probiotics encapsulated with other metal ions.

[0108] The present invention further explores the encapsulation effect of different probiotics. The acid resistance of probiotics before and after encapsulation is compared ( Figure 5 , Examples 11-16) were used to demonstrate the encapsulation effect. The results showed that compared with the unencapsulated strains, the acid resistance of the encapsulated strains was significantly improved, among which CoatedLbp 11, Coated Lpp 12, Coated Stt 13, CoatedLls 14, CoatedBl 15 and CoatedLbr 16 had 7.93Log 10 CFUs, 8.45Log 10 CFUs, 8.59Log 10 CFUs, 8.36Log 10 CFUs, 8.07Log 10 CFUs and 8.14Log 10 CFUs are viable cells.

[0109] In order to verify that different polyphenols encapsulated at the concentration ratio specified in the present invention still have an acid protection effect, in addition to EGCG, we also used epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), gallic acid, procyanidin and ellagic acid to encapsulate probiotics (Examples 17-22), and explored their acid resistance before and after encapsulation. The results are shown in Figure 6The results showed that different types of polyphenols can achieve ideal acid resistance by encapsulating probiotics according to the method and proportion specified in the present invention. Among them, CoatedLbp 17, CoatedLlf18, Coated Lls 19, CoatedLlf20, CoatedLlf21 and CoatedLlf22 have 8.59Log 10 CFUs, 7.51Log 10 CFUs, 8.59Log 10 CFUs, 8.59Log 10 CFUs, 8.68Log 10 CFUs and 8.66Log 10 CFUs are viable cells.

[0110] The above results indicate that within the concentration range specified in the present invention, both the protective layer formed by a single metal and polyphenols and the protective layer formed by a composite metal ion and polyphenols have good acid resistance effects, but in comparison, the effect of zinc ions and polyphenols on the encapsulation of probiotics is the best.

[0111] The digestive tract protection effect of the encapsulation layer was further verified by comparing the growth of Llf before and after simulated digestion. The results showed that the presence of the protective layer did not affect the growth and reproduction of Llf; secondly, after digestion, CoatedLlf3 still had high activity and had no significant difference in growth from the undigested strain; while after digestion, Llf had low activity and the OD value did not increase until after 16 hours of cultivation ( Figure 7 ).

[0112] 2. Characterization of Encapsulated Probiotics:

[0113] (1) Particle size and potential changes

[0114] The present invention measured the particle size and potential of the fermented Lactobacillus mucilaginosus (Llf) before and after single-cell nanoencapsulation in Example 3, and the results were as follows: Figure 8 and Fig. 9 The results showed that after encapsulation, the particle size of CoatedLlf3 increased and the zeta potential on the cell surface decreased, which preliminarily verified the existence of the encapsulation layer.

[0115] (2) Laser confocal microscopy imaging

[0116] Llf was labeled with Hoechst 33342 dye, while catechin-metal coating was labeled with FITC. Llf and CoatedLlf3 were imaged using confocal laser scanning microscopy ( Fig.10), the results showed that the outer layer of the cells of CoatedLlf3 had obvious green fluorescence, indicating that there was an encapsulation layer outside the cells of CoatedLlf3, and it can be found that the outer layer of each bacterium (Llf, blue fluorescence) contained green fluorescence, which also shows that the encapsulation method described in the present invention has a high encapsulation rate.

[0117] (3) Transmission electron microscopy imaging

[0118] Transmission electron microscopy was used to characterize the morphology and structure of Llf and the encapsulated probiotics (CoatedLlf3) prepared in Example 3. The results are as follows: Fig.11 Transmission electron microscopy images showed that there was a circle of transparent layer on the surface of CoatedLlf3 cells, and this layer was completely coated on the Llf surface, further verifying the existence and integrity of the encapsulation layer.

[0119] (4) The inventors tested the particle size and potential changes, laser confocal microscopy imaging and transmission electron microscopy imaging of the encapsulated probiotics in other embodiments (embodiments 1, 2, 4-22), and obtained similar results to the probiotics obtained in Example 3. Although the encapsulated probiotics in Examples 9 and 10 have an outer layer, the outer layer is relatively thin and therefore does not have acid resistance. This further illustrates that the encapsulated probiotics are effective only when the ratio of the metal ion to the hydroxyl concentration of polyphenols reaches a certain level.

[0120] 3. In vitro efficacy evaluation of encapsulated probiotics:

[0121] (1) Enhances the in vitro antioxidant capacity of Llf cells

[0122] The in vitro antioxidant capacity of Llf and CoatedLlf3 prepared in Example 3 was measured by measuring the free radical scavenging capacity of Llf. The free radical scavenging capacity measuring method is as follows:

[0123] DPPH scavenging rate: After the encapsulated probiotics were appropriately diluted, 1 mL of the sample was mixed evenly with 1 mL of 0.2 mmol / LDPPH solution and reacted in the dark for 30 min, and then the absorbance was measured at 517 nm.

[0124] ABTS clearance rate: Take 3.75mg / mL ABTS diammonium salt stock solution and 0.71mg / mL K2S2O8 stock solution and mix them in equal volumes. Place them at room temperature in a dark environment for 12 to 16 hours, then dilute the mixture with anhydrous ethanol to make the absorbance at 734nm 0.70±0.02. Take 10μL sample and mix with 990μL ABTS ·+ The free radical working solution was mixed and fully reacted for 10 minutes, and then the absorbance was measured at a wavelength of 734 nm.

[0125] Hydroxyl free radical scavenging rate: Mix 1 mL each of 5 mmol / L FeSO4 solution, 5 mmol / L salicylic acid-ethanol solution and 3 mmol / L hydrogen peroxide solution to prepare a working solution. Take 300 μL of the working solution and add 100 μL of the probiotic suspension, then add 600 μL of distilled water. React in a 37°C water bath for 15 min, centrifuge at 6000 r / min for 10 min, take the supernatant, and measure the absorbance at 510 nm.

[0126] The results are as follows Fig.12 As shown, compared with Llf, the scavenging ability of CoatedLlf3 for DPPH, ABTS and hydroxyl radicals is significantly improved, indicating that the protective layer formed by catechin-metal in the present invention can be used as "armor" to prevent free radicals from attacking Llf, thereby improving the antioxidant capacity of Llf.

[0127] (2) Can reduce the accumulation of reactive oxygen species in cells

[0128] Caco 2 cells were used to investigate the ability of encapsulated probiotics to reduce the formation or accumulation of intracellular reactive oxygen species. Briefly, a certain amount of culture medium containing H2O2 and probiotics was added to Caco 2 cells, incubated at 37°C for 2 hours, the culture medium was washed away, DCFH-DA, DAPI and PI were added for staining for 30 minutes, the stain was washed away, and the fluorescence of the cells was observed under a laser confocal microscope. Fig.13 As shown in the figure, the accumulation of reactive oxygen species in Caco 2 cells by the additional addition of Llf and CoatedLlf3 prepared in Example 3 under the stimulation of H2O2 is shown. It is found that compared with Caco 2 cells without any addition of any substance and Caco 2 cells with the addition of Llf, the green fluorescence of Caco-2 cells after the addition of CoatedLlf3 is significantly weakened, indicating that the presence of CoatedLlf3 can significantly reduce the accumulation of reactive oxygen species in cells. It can be shown that the presence of the encapsulation layer can alleviate the accumulation of reactive oxygen species in cells and improve the body's antioxidant level.

[0129] (3) Can enhance the adhesion ability of Llf cells

[0130] Caco 2 cells were used to investigate the adhesion ability of encapsulated probiotics. Probiotics were added to differentiated Caco-2 cells in a 24-well plate and co-cultured in a cell culture incubator at 37°C, 5% CO2, and 95% air for 2 hours. After washing twice with sterile PBS to remove non-adherent bacteria, 250 μL of 0.25% trypsin was added and incubated in a 37°C incubator for 5 minutes to release the bacteria that had adhered to the cells. Subsequently, 250 μL of complete culture medium without double-antibody DMEM was added to each well of the culture plate to terminate the activity of trypsin, and the Caco-2 cell layer was blown down with a 1 mL pipette. After the adherent bacteria were diluted 10 times with sterile saline, they were spread on MRS solid culture medium plates for plate colony counts ( Fig.14 The results showed that the adhesion of CoatedLlf3 to Caco-2 cells was significantly improved, indicating that the protective layer formed by catechin-metal can serve as a "tentacle" to enhance the adhesion of Llf, thereby improving the adhesion ability of Llf.

[0131] The present invention describes the above-mentioned embodiments, but the embodiments of the present invention are not limited to the above-mentioned specific implementation methods. The above-mentioned specific implementation methods are merely illustrative and not restrictive. Ordinary technicians in this field can also make many forms under the guidance of this embodiment, all of which belong to the protection scope of the present invention.

Claims

1. A method for encapsulating single cells of probiotic bacteria with acid resistance, antioxidant properties and strong adhesion, characterized in that: The following steps are involved: (1) resuspending the probiotics in a buffer to prepare a probiotic solution; (2) adding a metal salt aqueous solution to the probiotic solution obtained in step (1) and vortexing; (3) adding the polyphenol solution to the solution obtained in step (2), vortexing, and obtaining a bacterial suspension; (4) centrifuging the bacterial suspension obtained in step (3); (5) resuspending and centrifuging with PBS buffer to remove unbound polyphenols to obtain encapsulated probiotics, i.e., encapsulated probiotics; Among them, in the encapsulation system formed by mixing the probiotic solution, the metal salt aqueous solution and the polyphenol solution, the concentration of the probiotics is: 1×10 7- 1×10 9 CFU / mL, the metal ion concentration is 0.004-1mmol / mL, the hydroxyl concentration of the polyphenol is 0.002-0.05mmol / mL, and the molar concentration of the metal ions in the whole system is not less than the molar concentration of the hydroxyl contained in the polyphenol in the polyphenol solution.

2. The packaging method according to claim 1, characterized in that: The operation method of step (1) is: The cultured probiotics were washed three times with PBS buffer and 1×10 7- 1×10 9 The probiotics at CFU / mL were resuspended in 450 μL PBS buffer with a pH of 7.4 and vortexed for 15 s to evenly disperse the bacteria.

3. The packaging method according to claim 2, characterized in that: The operation method of step (2) is: add 50 μL of metal salt aqueous solution to the probiotic solution obtained in step (1), and vortex rapidly for 15 seconds.

4. The packaging method according to claim 3, characterized in that: The operation method of step (3) is as follows: add 500 μL of polyphenol solution to the solution obtained in step (2), vortex for 15 seconds, and obtain a bacterial suspension.

5. The packaging method according to claim 4, characterized in that: The operation method of step (4) is: centrifuge the bacterial suspension obtained in step (3) at 12000 rpm / min for 5-10 minutes.

6. The packaging method according to claim 5, characterized in that: The operation method of step (5) is: resuspend the product obtained in step (4) three times with PBS buffer and centrifuge at 5000-12000 rpm / min for 5-10 minutes to remove unbound polyphenols to obtain encapsulated probiotics, i.e., encapsulated probiotics.

7. The packaging method according to claim 1, characterized in that: The polyphenol is one or a mixture of tea polyphenols, proanthocyanidins, ellagic acid or catechin compounds.

8. The packaging method according to claim 7, characterized in that: The catechin compound is one or a mixture of epigallocatechin gallate (EGCG), epicatechin gallate (ECG), epigallocatechin (EGC), and epicatechin (EC).

9. The cell encapsulation method according to claim 1, characterized in that: The metal salt aqueous solution is an aqueous solution of a transition metal salt; the transition metal salt is one or a mixture of zinc salt, iron salt and manganese salt.

10. An encapsulated probiotic encapsulated by the encapsulation method according to any one of claims 1 to 9.

Citation Information

Cited By

  • Metal ion-mediated composite polysaccharide-based steady-state probiotic loading body as well as preparation method and application thereof

    CN120241651A